674
Views
48
CrossRef citations to date
0
Altmetric
Reviews

The effects of quercetin supplementation on lipid profiles and inflammatory markers among patients with metabolic syndrome and related disorders: A systematic review and meta-analysis of randomized controlled trials

, , , ORCID Icon, , , & show all

References

  • Arai, Y., S. Watanabe, M. Kimira, K. Shimoi, R. Mochizuki, and N. Kinae. 2000. Dietary intakes of flavonols, flavones and isoflavones by Japanese women and the inverse correlation between quercetin intake and plasma LDL cholesterol concentration. The Journal of Nutrition 130 (9):2243–50. doi: 10.1093/jn/130.9.2243.
  • Askari, G., R. Ghiasvand, A. Feizi, S. M. Ghanadian, and J. Karimian. 2012. The effect of quercetin supplementation on selected markers of inflammation and oxidative stress. Journal of Research in Medical Sciences 17 (7):637–41.
  • Beekmann, K., L. Rubio, L. H. de Haan, L. Actis-Goretta, B. van der Burg, P. J. van Bladeren, and I. M. Rietjens. 2015. The effect of quercetin and kaempferol aglycones and glucuronides on peroxisome proliferator-activated receptor-gamma (PPAR-γ). Food & Function 6 (4):1098–107. doi: 10.1039/c5fo00076a.
  • Bhaskar, S., K. S. Kumar, K. Krishnan, and H. Antony. 2013. Quercetin alleviates hypercholesterolemic diet induced inflammation during progression and regression of atherosclerosis in rabbits. Nutrition 29 (1):219–29. doi: 10.1016/j.nut.2012.01.019.
  • Bhaskar, S., P. R. Sudhakaran, and A. Helen. 2016. Quercetin attenuates atherosclerotic inflammation and adhesion molecule expression by modulating TLR-NF-κB signaling pathway. Cellular Immunology 310:131–40. doi: 10.1016/j.cellimm.2016.08.011.
  • Browning, J. D., and J. D. Horton. 2004. Molecular mediators of hepatic steatosis and liver injury. The Journal of Clinical Investigation 114 (2):147–52. doi: 10.1172/JCI22422.
  • Brüll, V., C. Burak, B. Stoffel-Wagner, S. Wolffram, G. Nickenig, C. Müller, P. Langguth, B. Alteheld, R. Fimmers, P. Stehle, and S. Egert. 2017a. Acute intake of quercetin from onion skin extract does not influence postprandial blood pressure and endothelial function in overweight-to-obese adults with hypertension: A randomized, double-blind, placebo-controlled, crossover trial. European Journal of Nutrition 56 (3):1347–57. doi: 10.1007/s00394-016-1185-1.
  • Brüll, V., C. Burak, B. Stoffel-Wagner, S. Wolffram, G. Nickenig, C. Muller, P. Langguth, B. Alteheld, R. Fimmers, P. Stehle, and S. Egert. 2017b. No effects of quercetin from onion skin extract on serum leptin and adiponectin concentrations in overweight-to-obese patients with (pre-) hypertension: A randomized double-blinded, placebo-controlled crossover trial. European Journal of Nutrition 56 (7):2265–75. doi: 10.1007/s00394-016-1267-0.
  • Brüll, V., C. Burak, B. Stoffel-Wagner, S. Wolffram, G. Nickenig, C. Muller, P. Langguth, B. Alteheld, R. Fimmers, S. Naaf, et al. 2015. Effects of a quercetin-rich onion skin extract on 24 h ambulatory blood pressure and endothelial function in overweight-to-obese patients with (pre-)hypertension: A randomised double-blinded placebo-controlled cross-over trial. The British Journal of Nutrition 114 (8):1263–77. doi: 10.1017/S0007114515002950.
  • Castilla, P., R. Echarri, A. Davalos, F. Cerrato, H. Ortega, J. L. Teruel, M. F. Lucas, D. Gomez-Coronado, J. Ortuno, and M. A. Lasuncion. 2006. Concentrated red grape juice exerts antioxidant, hypolipidemic, and antiinflammatory effects in both hemodialysis patients and healthy subjects. The American Journal of Clinical Nutrition 84 (1):252–62. doi: 10.1093/ajcn/84.1.252.
  • Chekalina, N. I., Y. M. Kazakov, T. V. Mamontova, L. E. Vesnina, and I. P. Kaidashev. 2016. Resveratrol more effectively than quercetin reduces endothelium degeneration and level of necrosis factor alpha in patients with coronary artery disease. Wiadomości Lekarskie 69 (3 pt 2):475–9.
  • Chen, P., Q. Shi, X. Xu, Y. Wang, W. Chen, and H. Wang. 2012. Quercetin suppresses NF-kappaB and MCP-1 expression in a high glucose-induced human mesangial cell proliferation model. International Journal of Molecular Medicine 30 (1):119–25.
  • Cialdella-Kam, L., D. Nieman, A. Knab, R. Shanely, M. Meaney, F. Jin, W. Sha, and S. Ghosh. 2016. A mixed flavonoid-fish oil supplement induces immune-enhancing and anti-inflammatory transcriptomic changes in adult obese and overweight women—A randomized controlled trial. Nutrients 8 (5):277. doi: 10.3390/nu8050277.
  • Cicero, A. F., M. Morbini, A. Parini, R. Urso, M. Rosticci, E. Grandi, and C. Borghi. 2016. Effect of red yeast rice combined with antioxidants on lipid pattern, hs-CRP level, and endothelial function in moderately hypercholesterolemic subjects. Therapeutics and Clinical Risk Management 12:281–6. doi: 10.2147/TCRM.S91817.
  • Clifton, P. M. 2004. Effect of grape seed extract and quercetin on cardiovascular and endothelial parameters in high-risk subjects. Journal of Biomedicine &Amp; Biotechnology 2004 (5):272–8. doi: 10.1155/S1110724304403088.
  • Das, N., K. Sikder, S. Bhattacharjee, S. B. Majumdar, S. Ghosh, S. Majumdar, and S. Dey. 2013. Quercetin alleviates inflammation after short-term treatment in high-fat-fed mice. Food & Function 4 (6):889–98. doi: 10.1039/c3fo30241e.
  • Edwards, R. L., T. Lyon, S. E. Litwin, A. Rabovsky, J. D. Symons, and T. Jalili. 2007. Quercetin reduces blood pressure in hypertensive subjects. The Journal of Nutrition 137 (11):2405–11. doi: 10.1093/jn/137.11.2405.
  • Egert, S., A. Bosy-Westphal, J. Seiberl, C. Kürbitz, U. Settler, S. Plachta-Danielzik, A. E. Wagner, J. Frank, J. Schrezenmeir, G. Rimbach, et al. 2009. Quercetin reduces systolic blood pressure and plasma oxidised low-density lipoprotein concentrations in overweight subjects with a high-cardiovascular disease risk phenotype: A double-blinded, placebo-controlled cross-over study. The British Journal of Nutrition 102 (7):1065–74. doi: 10.1017/S0007114509359127.
  • Egert, S., C. Boesch-Saadatmandi, S. Wolffram, G. Rimbach, and M. J. Muller. 2010. Serum lipid and blood pressure responses to quercetin vary in overweight patients by apolipoprotein E genotype. The Journal of Nutrition 140 (2):278–84. doi: 10.3945/jn.109.117655.
  • Kumazawa, Y., K. Kawaguchi, and H. Takimoto. 2006. Immunomodulating effects of flavonoids on acute and chronic inflammatory responses caused by tumor necrosis factor alpha. Current Pharmaceutical Design 12 (32):4271–9.
  • Lee, K. H., E. Park, H. J. Lee, M. O. Kim, Y. J. Cha, J. M. Kim, H. Lee, and M. J. Shin. 2011. Effects of daily quercetin-rich supplementation on cardiometabolic risks in male smokers. Nutrition Research and Practice 5 (1):28–33. doi: 10.4162/nrp.2011.5.1.28.
  • Lee, K.-H., Y.-H. Kim, E.-J. Park, and S.-R. Cho. 2008. Study on dietary habit and effect of onion powder supplementation on serum lipid levels in early diagnosed hyperlipidemic patients. Journal of the Korean Society of Food Science and Nutrition 37 (5):561–70. doi: 10.3746/jkfn.2008.37.5.561.
  • Loke, W. M., J. M. Proudfoot, S. Stewart, A. J. McKinley, P. W. Needs, P. A. Kroon, J. M. Hodgson, and K. D. Croft. 2008. Metabolic transformation has a profound effect on anti-inflammatory activity of flavonoids such as quercetin: Lack of association between antioxidant and lipoxygenase inhibitory activity. Biochemical Pharmacology 75 (5):1045–53. doi: 10.1016/j.bcp.2007.11.002.
  • Lotito, S. B., and B. Frei. 2006. Dietary flavonoids attenuate tumor necrosis factor alpha-induced adhesion molecule expression in human aortic endothelial cells. Structure-function relationships and activity after first pass metabolism. The Journal of Biological Chemistry 281 (48):37102–10. doi: 10.1074/jbc.M606804200.
  • Lu, T.-M., H.-F. Chiu, Y.-C. Shen, C.-C. Chung, K. Venkatakrishnan, and C.-K. Wang. 2015. Hypocholesterolemic efficacy of quercetin rich onion juice in healthy mild hypercholesterolemic adults: A pilot study. Plant Foods for Human Nutrition (Dordrecht, Netherlands) 70 (4):395–400. doi: 10.1007/s11130-015-0507-4.
  • Mamani-Matsuda, M., T. Kauss, A. Al-Kharrat, J. Rambert, F. Fawaz, D. Thiolat, D. Moynet, S. Coves, D. Malvy, and M. D. Mossalayi. 2006. Therapeutic and preventive properties of quercetin in experimental arthritis correlate with decreased macrophage inflammatory mediators. Biochemical Pharmacology 72 (10):1304–10. doi: 10.1016/j.bcp.2006.08.001.
  • Mazloom, Z., S. M. Abdollahzadeh, M. H. Dabbaghmanesh, and A. Rezaianzadeh. 2014. The effect of quercetin supplementation on oxidative stress, glycemic control, lipid profile and insulin resistance in type 2 diabetes: A randomized clinical trial. Journal of Health Sciences and Surveillance System 2 (1):8–14.
  • Mohammadi-Sartang, M., Z. Mazloom, S. Sherafatmanesh, M. Ghorbani, and D. Firoozi. 2017. Effects of supplementation with quercetin on plasma C-reactive protein concentrations: A systematic review and Meta-analysis of randomized controlled trials. European Journal of Clinical Nutrition 71 (9):1033–9. doi: 10.1038/ejcn.2017.55.
  • Mollazadeh, H., F. Carbone, F. Montecucco, M. Pirro, and A. Sahebkar. 2018. Oxidative burden in familial hypercholesterolemia. Journal of Cellular Physiology 233 (8):5716–25. doi: 10.1002/jcp.26466.
  • Morel, I., G. Lescoat, P. Cogrel, O. Sergent, N. Pasdeloup, P. Brissot, P. Cillard, and J. Cillard. 1993. Antioxidant and iron-chelating activities of the flavonoids catechin, quercetin and diosmetin on iron-loaded rat hepatocyte cultures. Biochemical Pharmacology 45 (1):13–9.
  • Naderi, G. A., S. Asgary, N. Sarraf-Zadegan, and H. Shirvany. 2003. Anti-oxidant effect of flavonoids on the susceptibility of LDL oxidation. Molecular and Cellular Biochemistry 246 (1–2):193–6.
  • Nedoborenko, V., I. Kaidashev, A. Lavrenko, L. Vesnina, and T. Mamontova. 2017. Inclusion of quercetin in treatment reduces the level of interleukin 6 in women with iron deficiency anemia and obesity. Marine Ecology Problems 21 (5–6):37–9.
  • Nieman, D. C., S. Ramamoorthy, C. D. Kay, C. L. Goodman, C. R. Capps, Z. L. Shue, N. Heyl, M. H. Grace, and M. A. Lila. 2017. Influence of ingesting a flavonoid-rich supplement on the metabolome and concentration of urine phenolics in overweight/obese women. Journal of Proteome Research 16 (8):2924–35. doi: 10.1021/acs.jproteome.7b00196.
  • Panicker, S. R., P. Sreenivas, M. S. Babu, D. Karunagaran, and C. C. Kartha. 2010. Quercetin attenuates monocyte chemoattractant protein-1 gene expression in glucose primed aortic endothelial cells through NF-kappaB and AP-1. Pharmacological Research 62 (4):328–36. doi: 10.1016/j.phrs.2010.06.003.
  • Pasceri, V., J. T. Willerson, and E. T. Yeh. 2000. Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation 102 (18):2165–8.
  • Peet, G. W., and J. Li. 1999. IkappaB kinases alpha and beta show a random sequential kinetic mechanism and are inhibited by staurosporine and quercetin. The Journal of Biological Chemistry 274 (46):32655–61.
  • Qureshi, A. A., D. A. Khan, W. Mahjabeen, C. J. Papasian, and N. Qureshi. 2013. Nutritional supplement-5 with a combination of proteasome inhibitors (resveratrol, quercetin, delta-tocotrienol) modulate age-associated biomarkers and cardiovascular lipid parameters in human subjects. Journal of Clinical and Experimental Cardiology 4 (3):238.
  • Ridker, P. M. 2009. C-reactive protein: Eighty years from discovery to emergence as a major risk marker for cardiovascular disease. Clinical Chemistry 55 (2):209–15. doi: 10.1373/clinchem.2008.119214.
  • Rivera, L., R. Moron, M. Sanchez, A. Zarzuelo, and M. Galisteo. 2008. Quercetin ameliorates metabolic syndrome and improves the inflammatory status in obese zucker rats. Obesity 16 (9):2081–7. doi: 10.1038/oby.2008.315.
  • Shai, I., M. B. Schulze, J. E. Manson, K. M. Rexrode, M. J. Stampfer, C. Mantzoros, and F. B. Hu. 2005. A prospective study of soluble tumor necrosis factor-alpha receptor II (sTNF-RII) and risk of coronary heart disease among women with type 2 diabetes. Diabetes Care 28 (6):1376–82.
  • Stapleton, P. A., A. G. Goodwill, M. E. James, R. W. Brock, and J. C. Frisbee. 2010. Hypercholesterolemia and microvascular dysfunction: Interventional strategies. Journal of Inflammation 7 (1):54. doi: 10.1186/1476-9255-7-54.
  • Stokes, K. Y., D. Cooper, A. Tailor, and D. N. Granger. 2002. Hypercholesterolemia promotes inflammation and microvascular dysfunction: Role of nitric oxide and superoxide. Free Radical Biology & Medicine 33 (8):1026–36.
  • Tribolo, S., F. Lodi, C. Connor, S. Suri, V. G. Wilson, M. A. Taylor, P. W. Needs, P. A. Kroon, and D. A. Hughes. 2008. Comparative effects of quercetin and its predominant human metabolites on adhesion molecule expression in activated human vascular endothelial cells. Atherosclerosis 197 (1):50–6. doi: 10.1016/j.atherosclerosis.2007.07.040.
  • Venugopal, S. K., S. Devaraj, and I. Jialal. 2005. Effect of C-reactive protein on vascular cells: Evidence for a proinflammatory, proatherogenic role. Current Opinion in Nephrology and Hypertension 14 (1):33–7.
  • Yildirim, A., E. Senchenkova, and D. N. Granger. 2016. Hypercholesterolemia blunts the oxidative stress elicited by hypertension in venules through angiotensin II type-2 receptors. Microvascular Research 105:54–60. doi: 10.1016/j.mvr.2016.01.002.
  • Yoshizumi, M., K. Tsuchiya, Y. Suzaki, K. Kirima, M. Kyaw, J. H. Moon, J. Terao, and T. Tamaki. 2002. Quercetin glucuronide prevents VSMC hypertrophy by angiotensin II via the inhibition of JNK and AP-1 signaling pathway. Biochemical and Biophysical Research Communications 293 (5):1458–65. doi: 10.1016/S0006-291X(02)00407-2.
  • Zahedi, M., R. Ghiasvand, A. Feizi, G. Asgari, and L. Darvish. 2013. Does quercetin improve cardiovascular risk factors and inflammatory biomarkers in women with type 2 diabetes: A double-blind randomized controlled clinical trial. International Journal of Preventive Medicine 4 (7):777–85.
  • Zang, M., S. Xu, K. A. Maitland-Toolan, A. Zuccollo, X. Hou, B. Jiang, M. Wierzbicki, T. J. Verbeuren, and R. A. Cohen. 2006. Polyphenols stimulate AMP-activated protein kinase, lower lipids, and inhibit accelerated atherosclerosis in diabetic LDL receptor-deficient mice. Diabetes 55 (8):2180–91. doi: 10.2337/db05-1188.
  • Zern, T. L., R. J. Wood, C. Greene, K. L. West, Y. Liu, D. Aggarwal, N. S. Shachter, and M. L. Fernandez. 2005. Grape polyphenols exert a cardioprotective effect in pre- and postmenopausal women by lowering plasma lipids and reducing oxidative stress. The Journal of Nutrition 135 (8):1911–7. doi: 10.1093/jn/135.8.1911.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.